| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 16.05.
| Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan | | 53 | Business Wire |
| Sorin Group, (Reuters Code: SORN.MI), a global medical device company
and a leader in the treatment of cardiovascular diseases, announces that
it received authorization...
Mehr lesen zu:
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan | |
| 10.05.
| Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads | | 25 | Business Wire |
| New pacing, defibrillation and left ventricular leads, combined
with Sorin Group's innovative implantable devices enable effective
management of arrhythmias and heart...
Mehr lesen zu:
Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads | |
| 09.05.
| SORIN GROUP ANNOUNCES PUBLICATION OF FULL CLEAR STUDY RESULTS IN PEER REVIEWED CARDIOLOGY JOURNAL | | 27 | Business Wire |
| Results published in EUROPACE show significant improvement in
heart failure patients' response to cardiac resynchronization therapy
with Sorin'sinnovative SonR®1
...
Mehr lesen zu:
SORIN GROUP ANNOUNCES PUBLICATION OF FULL CLEAR STUDY RESULTS IN PEER REVIEWED CARDIOLOGY JOURNAL | |
| 08.05.
| Sorin Group Announces FDA Approval and Commercial Launch of PARADYM(TM) RF ICDs and CRT-D Implantable Heart Devices | | 42 | Business Wire |
| New family of implantable cardioverter defibrillators and cardiac
resynchronization devices are enabled for remote monitoring
Sorin Group, (Reuters...
Mehr lesen zu:
Sorin Group Announces FDA Approval and Commercial Launch of PARADYM(TM) RF ICDs and CRT-D Implantable Heart Devices | |
| 23.04.
| Sorin Group: Solid Start to 2012: Underlying Revenue Growth of 2.8%* in the First Quarter | | 28 | Business Wire |
| Consolidated results for the first quarter of 2012:
Revenues of €191.7 million, a 2.8%*
increase (5.1% as reported) over the first quarter of 2011...
Mehr lesen zu:
Sorin Group: Solid Start to 2012: Underlying Revenue Growth of 2.8%* in the First Quarter | |
| 21.02.
| Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve | | 41 | Business Wire |
| Sorin Group, (MIL:SRN)(Reuters Code: SORN.MI), a global medical company
and a leader in the treatment of cardiovascular diseases, today
announced initiation of a United...
Mehr lesen zu:
Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve | |
| 09.02.
| Sorin: Preliminary Results for 2011: Net Profit Increases by 48.5% | | 47 | Business Wire |
| Sorin (MIL:SRN):
Consolidated results for the fourth quarter of 2011:
Revenues of €197.9 million, a 0.8%1 increase (+1.2% as
...
Mehr lesen zu:
Sorin: Preliminary Results for 2011: Net Profit Increases by 48.5% | |
| 31.01.
| Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads | | 52 | Business Wire |
| New lead portfolio combined with Sorin Group's innovative and
intelligent devices provide full-featured systems for accurate
management of arrhythmias and heart failure
...
Mehr lesen zu:
Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads | |
| 27.01.
| Sorin Group Opens New International Training Center for Healthcare Professionals | | 55 | Business Wire |
| With the opening of its newest training center in France, Sorin
re-affirms its long-term commitment to the healthcare community
Sorin Group, (MIL:SRN)...
Mehr lesen zu:
Sorin Group Opens New International Training Center for Healthcare Professionals | |
| 05.12.
| Sorin Group Announces CE Mark of INSPIRE(TM) New Family of Adult Oxygenators | | 29 | Business Wire |
| Sorin Group receives European market clearance for the INSPIRE(TM)
Adult Oxygenators,
designed to offer a truly optimized
approach to perfusion
...
Mehr lesen zu:
Sorin Group Announces CE Mark of INSPIRE(TM) New Family of Adult Oxygenators | |
